Skip to main content
logo
ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
585.00
+5.00 (0.86%)
At close: Jul 31, 2026

KOSDAQ:034940 Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
59,62059,31162,69462,97468,88057,561
Revenue Growth
-3.73%-5.40%-0.45%-8.57%19.66%-11.93%
Gross Profit
21,79121,87421,19923,76126,24220,309
Operating Income
-5,612-6,598-9,828-8,792-482.21-7,003
Net Income
-4,727-6,806-9,605-10,514560.69-8,044
Earnings Per Share
-152.73-219.68-310.00-339.3918.10-259.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,0252,5235,4474,3618,44910,184
Total Debt
27,55927,30524,68917,50118,67816,474
Net Cash (Debt)
-24,534-24,782-19,242-13,141-10,229-6,289
Net Cash Growth
------
Net Cash Per Share
-792.74-799.95-621.05-424.17-330.17-203.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3,518-4,180-4,468-1,475-1,443-1,480
Capital Expenditures
-2,024-1,986-551.31-831.13-2,782-3,544
Free Cash Flow
-5,542-6,165-5,019-2,306-4,225-5,024
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
36.55%36.88%33.81%37.73%38.10%35.28%
Operating Margin
-9.41%-11.13%-15.68%-13.96%-0.70%-12.17%
Pretax Margin
-7.33%-10.83%-16.00%-17.36%-0.62%-12.42%
Profit Margin
-7.93%-11.47%-15.32%-16.70%0.81%-13.97%
FCF Margin
-9.30%-10.39%-8.01%-3.66%-6.13%-8.73%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----130.12-
PS Ratio
0.300.530.480.981.062.02